These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 1748606

  • 1. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK, Davidson MG, English RV, Nasisse MP, Jamieson VE, Gerig TM.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1039-42. PubMed ID: 1748606
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R, Lambrou GN, Allgoewer I, Graenitz U, Pena TM, Spiess BM, Latour E.
    Vet J; 2009 Jan 15; 179(1):70-7. PubMed ID: 17950639
    [Abstract] [Full Text] [Related]

  • 3. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV, Abrams KL.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1043-6. PubMed ID: 1748607
    [Abstract] [Full Text] [Related]

  • 4. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A, English RV, Nadelstein B.
    Vet Ophthalmol; 2005 Oct 15; 8(4):225-32. PubMed ID: 16008701
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP, McHugh JB, Thorne JG, Phillips TE.
    Invest Ophthalmol Vis Sci; 2001 Mar 15; 42(3):653-9. PubMed ID: 11222523
    [Abstract] [Full Text] [Related]

  • 6. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ, Kaswan RM, Bounous DI, Hirsh SG.
    J Am Optom Assoc; 1995 Jul 15; 66(7):397-404. PubMed ID: 7560726
    [Abstract] [Full Text] [Related]

  • 7. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
    Barachetti L, Rampazzo A, Mortellaro CM, Scevola S, Gilger BC.
    Vet Ophthalmol; 2015 May 15; 18(3):234-41. PubMed ID: 24799029
    [Abstract] [Full Text] [Related]

  • 8. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C, Celik I, Alkan F, Erol M, Sur E.
    Biotech Histochem; 2015 Apr 15; 90(3):223-30. PubMed ID: 25747049
    [Abstract] [Full Text] [Related]

  • 9. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
    Izci C, Celik I, Alkan F, Ogurtan Z, Ceylan C, Sur E, Ozkan Y.
    Am J Vet Res; 2002 May 15; 63(5):688-94. PubMed ID: 12013470
    [Abstract] [Full Text] [Related]

  • 10. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C.
    Invest Ophthalmol Vis Sci; 2001 Jan 15; 42(1):90-5. PubMed ID: 11133852
    [Abstract] [Full Text] [Related]

  • 11. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K, Balicki I.
    Acta Vet Hung; 2016 Sep 15; 64(3):313-329. PubMed ID: 27653428
    [Abstract] [Full Text] [Related]

  • 12. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
    Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME.
    Cornea; 1998 Nov 15; 17(6):654-63. PubMed ID: 9820947
    [Abstract] [Full Text] [Related]

  • 13. Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Gilger BC, Andrews J, Wilkie DA, Wyman M, Lairmore MD.
    Vet Immunol Immunopathol; 1995 Dec 15; 49(3):199-208. PubMed ID: 8746695
    [Abstract] [Full Text] [Related]

  • 14. Severe, unilateral, unresponsive keratoconjunctivitis sicca in 16 juvenile Yorkshire Terriers.
    Herrera HD, Weichsler N, Gómez JR, de Jalón JA.
    Vet Ophthalmol; 2007 Dec 15; 10(5):285-8. PubMed ID: 17760706
    [Abstract] [Full Text] [Related]

  • 15. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
    Nell B, Walde I, Billich A, Vit P, Meingassner JG.
    Vet Ophthalmol; 2005 Dec 15; 8(1):39-46. PubMed ID: 15644099
    [Abstract] [Full Text] [Related]

  • 16. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O, Baudouin C, Pisella PJ, Brignole F.
    J Fr Ophtalmol; 2003 Apr 15; 26(4):337-43. PubMed ID: 12843889
    [Abstract] [Full Text] [Related]

  • 17. Lack of effects on lymphocyte function from chronic topical ocular cyclosporine medication: a prospective study.
    Williams DL.
    Vet Ophthalmol; 2010 Sep 15; 13(5):315-20. PubMed ID: 20840109
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL, Salisbury MA, Ward DA.
    Arch Ophthalmol; 1989 Aug 15; 107(8):1210-6. PubMed ID: 2757551
    [Abstract] [Full Text] [Related]

  • 19. A comparative approach to topical cyclosporine therapy.
    Williams DL.
    Eye (Lond); 1997 Aug 15; 11 ( Pt 4)():453-64. PubMed ID: 9425407
    [Abstract] [Full Text] [Related]

  • 20. A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs.
    Gilger BC, Wilkie DA, Salmon JH, Peel MR.
    Vet Ophthalmol; 2013 May 15; 16(3):192-7. PubMed ID: 22853450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.